KevinB.KimMD

Clinical Trials

• Imatinib Mesylate in Treating Patients With Metastatic Melanoma Start of enrollment: 2001 Sep 01

  Completed

  Phase 2

• Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma Start of enrollment: 2005 Mar 01

  Unknown status

  Phase 2

• Sample Collection From Melanoma Patients Start of enrollment: 2006 Jun 13

  Terminated

• Taxotere/Temodar/Cisplatin Study in Melanoma Patients Start of enrollment: 2004 Aug 01

  Completed

  Phase 1

• A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) Start of enrollment: 2007 Dec 14

  Active, not recruiting

  Phase 1

• Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma Start of enrollment: 2011 Mar 01

  Terminated

  Phase 2

• A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma Start of enrollment: 2013 Jun 01

  Completed

  Phase 1, Phase 2

• Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases Start of enrollment: 2016 Oct 10

  Active, not recruiting

  Phase 1, Phase 2

• Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma Start of enrollment: 2019 Oct 28

  Active, not recruiting

  Phase 3

• Join now to see all